ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
58 |
16K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
58 |
16K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
MTC
|
12K |
4.2M |
10 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix to Present at Euroz Hartleys Conference
|
|
MTC
|
112 |
28K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
112
|
28K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
MTC
|
247 |
72K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
247
|
72K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
MTC
|
159 |
49K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
159
|
49K
|
3
|
|
ASX - By Stock
|
VRX |
Re:
Ann: Arrowsmith North Updated BFS
|
|
MTC
|
149 |
31K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
149
|
31K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
6 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
MTC
|
12K |
4.2M |
8 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
MTC
|
12K |
4.2M |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
MTC
|
12K |
4.2M |
10 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
12K
|
4.2M
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
MTC
|
622 |
194K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
622
|
194K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
MTC
|
1.1K |
295K |
19 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
MTC
|
1.1K |
295K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
MTC
|
12K |
4.2M |
12 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
12K
|
4.2M
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
MTC
|
311 |
77K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
311
|
77K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Chart & more
|
|
MTC
|
15 |
5.0K |
11 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
15
|
5.0K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
MTC
|
209 |
49K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
MTC
|
209 |
49K |
13 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
MTC
|
209 |
49K |
23 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
MTC
|
209 |
49K |
16 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
49K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
114 |
32K |
13 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
114 |
32K |
12 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
114 |
32K |
6 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
114 |
32K |
14 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
MTC
|
114 |
32K |
7 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
MTC
|
323 |
74K |
20 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
323
|
74K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
MTC
|
282 |
73K |
22 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
282
|
73K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: EGM Shareholder Presentation
|
|
MTC
|
45 |
12K |
16 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
45
|
12K
|
16
|
|
ASX - By Stock
|
BRN |
Re:
2024 BrainChip Discussion
|
|
MTC
|
4.4K |
1.7M |
9 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
4.4K
|
1.7M
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
MTC
|
282 |
73K |
8 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
282
|
73K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
13 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
MTC
|
1.1K |
295K |
8 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
MTC
|
1.1K |
295K |
15 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
MTC
|
1.1K |
295K |
11 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1.1K
|
295K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
MTC
|
197 |
51K |
17 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
51K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Presentation and Non-Deal Roadshow
|
|
MTC
|
11 |
3.5K |
27 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
11
|
3.5K
|
27
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
MTC
|
112 |
35K |
14 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
112
|
35K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
MTC
|
112 |
35K |
2 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
112
|
35K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: NDA Resubmission Accepted and Approval Date Confirmed
|
|
MTC
|
112 |
35K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
112
|
35K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
MTC
|
430 |
106K |
25 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
430
|
106K
|
25
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
MTC
|
137 |
44K |
8 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
137
|
44K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
MTC
|
12K |
4.2M |
18 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
12K
|
4.2M
|
18
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
18 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
18
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
22 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
22
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
18 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
18
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
9 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
9
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
MTC
|
8.0K |
2.9M |
20 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
20
|
|
ASX - By Stock
|
TVN |
Re:
Some Light Relief
|
|
MTC
|
57 |
17K |
5 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
57
|
17K
|
5
|
|